MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, ONC has $8,188,573K in assets. $3,827,379K in debts. $4,547,530K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
340.85%
Quick Ratio
307.59%
Cash Ratio
248.66%
Debt to Asset Ratio
46.74%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Property and equipment, at cost
    • Accounts receivable, net
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accrued expenses and other payab...
    • Others

Balance Sheets
2025-12-31
Cash and cash equivalents
4,547,530
Accounts receivable, net
865,080
Inventories, net
608,227
Prepaid expenses and other current assets
212,752
Total current assets
6,233,589
Land
71,434
Building
1,187,836
Machinery And Equipment
273,769
Laboratory Equipment
309,471
Software And Software Development Costs
124,136
Leasehold Improvements
76,568
Property and equipment, at cost
2,043,214
Less accumulated depreciation
528,695
Construction in progress
127,159
Property, plant and equipment, net
1,641,678
Operating lease right-of-use assets
148,184
2026
6,293
2027-Cost Of Sales
6,226
2027-Selling General And Administrative Expenses
67
2027
6,293
2028
6,293
2030
6,293
2031 and thereafter
31,239
Intangible assets, net
62,704
Other non-current assets
102,418
Total non-current assets
1,954,984
Total assets
8,188,573
Accounts payable
479,035
Accrued expenses and other payables
1,109,120
Tax payable
41,625
Operating lease liabilities, current portion
20,698
Research and development cost share liability, current portion
64,345
Sale of future royalty liability, current portion
56,714
Short-term debt
57,293
Total current liabilities
1,828,830
Long-term debt
961,913
Sale of future royalty liability, non-current portion
850,242
Operating lease liabilities, non-current portion
52,940
Deferred tax liabilities
53,209
Research and development cost share liability, non-current portion
0
Other long-term liabilities
80,245
Total non-current liabilities
1,998,549
Total liabilities
3,827,379
Ordinary shares, 0.0001 par value per share 1,540,975,898 and 1,387,367,704 shares issued and 1,441,075,618 and 1,387,367,704 shares outstanding as of december31,2025 and 2024, respectively
144
Additional paid-in capital
12,759,137
Accumulated other comprehensive loss
-78,184
Accumulated deficit
-8,319,903
Total shareholders equity
4,361,194
Total liabilities and shareholders equity
8,188,573
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Building$1,187,836K Laboratory Equipment$309,471K Machinery And Equipment$273,769K Software And SoftwareDevelopment Costs$124,136K Leasehold Improvements$76,568K Land$71,434K Property and equipment,at cost$2,043,214K 2031 and thereafter$31,239K 2030$6,293K 2028$6,293K 2027$6,293K 2026$6,293K 2027-Cost Of Sales$6,226K 2027-Selling General AndAdministrative Expenses$67K Construction in progress$127,159K Cash and cashequivalents$4,547,530K Accounts receivable, net$865,080K Inventories, net$608,227K Prepaid expenses andother current assets$212,752K Property, plant andequipment, net$1,641,678K Operating leaseright-of-use assets$148,184K Other non-currentassets$102,418K Intangible assets, net$62,704K Less accumulateddepreciation$528,695K Total current assets$6,233,589K Total non-currentassets$1,954,984K Total assets$8,188,573K Total liabilities andshareholders equity$8,188,573K Total shareholdersequity$4,361,194K Total liabilities$3,827,379K Accumulated deficit-$8,319,903K Accumulated othercomprehensive loss-$78,184K Additional paid-in capital$12,759,137K Total non-currentliabilities$1,998,549K Total currentliabilities$1,828,830K Ordinary shares, 0.0001par value per share...$144K Long-term debt$961,913K Sale of futureroyalty liability,...$850,242K Other long-termliabilities$80,245K Deferred tax liabilities$53,209K Operating leaseliabilities, non-current...$52,940K Accrued expenses andother payables$1,109,120K Accounts payable$479,035K Research and developmentcost share...$64,345K Short-term debt$57,293K Sale of futureroyalty liability,...$56,714K Tax payable$41,625K Operating leaseliabilities, current portion$20,698K

BeOne Medicines Ltd. (ONC)

BeOne Medicines Ltd. (ONC)